These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8859931)

  • 1. Direct interactions of plasminogen activators with human aortic and pulmonary artery endothelial cells in vitro: implications for thrombolytic therapy.
    Yamada Y; Yokota M
    J Cardiovasc Pharmacol; 1996 May; 27(5):629-35. PubMed ID: 8859931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of protein kinase C activation and inhibition on endothelin-1 release from human aortic and pulmonary artery endothelial cells: comparison with effects on bovine endothelin-1 and human prostaglandin I2 release.
    Yamada Y; Yokota M
    Am J Hypertens; 1997 Jan; 10(1):32-42. PubMed ID: 9008246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of various plasminogen activators on prostacyclin synthesis in cultured vascular cells.
    Kawaguchi H; Yasuda H
    Circ Res; 1988 Dec; 63(6):1029-35. PubMed ID: 3143495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
    Shatos MA; Doherty JM; Penar PL; Sobel BE
    Circulation; 1996 Aug; 94(4):636-42. PubMed ID: 8772682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes.
    Smalling RW
    Am J Health Syst Pharm; 1997 Nov; 54 Suppl 1():S17-22. PubMed ID: 9397233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones.
    Sobel MI; Winkel CA; Macy LB; Liao P; Bjornsson TD
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):801-8. PubMed ID: 7573247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.
    Essig M; Nguyen G; Prié D; Escoubet B; Sraer JD; Friedlander G
    Circ Res; 1998 Oct; 83(7):683-90. PubMed ID: 9758637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbation of platelet adhesion to endothelial cells by plasminogen activation in vitro.
    Chen H; Wu YI; Hsieh YL; Shi GY; Jiang MJ; Chang WC; Chuang WJ; Kan WM; Tang MJ; Jen CJ
    Thromb Haemost; 1997 Aug; 78(2):934-8. PubMed ID: 9268198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell injury induced by plasmin in vitro.
    Okajima K; Abe H; Binder BR
    J Lab Clin Med; 1995 Oct; 126(4):377-84. PubMed ID: 7561447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F; Wilson EL; Mignatti P; Rifkin DB
    J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-specific thrombolytic agents.
    Collen D
    Ann Biol Clin (Paris); 1988; 46(3):195-200. PubMed ID: 3044205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
    Flaumenhaft R; Abe M; Mignatti P; Rifkin DB
    J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin-induced secretion of an active plasminogen activator inhibitor from bovine pulmonary arterial and aortic endothelial cells.
    Crutchley DJ; Conanan LB; Ryan US
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1346-53. PubMed ID: 3120714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.